Works matching IS 00071188 AND DT 2019 AND VI 176 AND IP 14

Results: 22

Adrenoceptors-New roles for old players.

Published in:

2019

By:

Michel, Martin C.;
Bond, Richard A.;
Summers, Roger J.

Publication type:

Editorial

Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.

Published in:

2019

By:

Wang, Yi;
Fang, Qilu;
Jin, Yiyi;
Liu, Zhoudi;
Zou, Chunpeng;
Yu, Weihui;
Li, Weixin;
Shan, Xiaoou;
Chen, Ruijie;
Khan, Zia;
Liang, Guang

Publication type:

journal article

Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.

Published in:

2019

By:

Xu, Zheng;
Zou, Chunpeng;
Yu, Weihui;
Xu, Sujing;
Huang, Lan;
Khan, Zia;
Wang, Jingying;
Liang, Guang;
Wang, Yi

Publication type:

journal article

Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT1 /bradykinin B2 receptor heterodimerization.

Published in:

2019

By:

Anton, Elaine Leocádia;
Fernandes, Daniel;
Assreuy, Jamil;
Silva‐Santos, José Eduardo;
da Silva-Santos, José Eduardo

Publication type:

journal article

Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB1 receptors.

Published in:

2019

By:

Zhu, Xiao;
Finlay, David B.;
Glass, Michelle;
Duffull, Stephen B.

Publication type:

journal article

(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.

Published in:

2019

By:

Zanos, Panos;
Highland, Jaclyn N.;
Liu, Xin;
Troppoli, Timothy A.;
Georgiou, Polymnia;
Lovett, Jacqueline;
Morris, Patrick J.;
Stewart, Brent W.;
Thomas, Craig J.;
Thompson, Scott M.;
Moaddel, Ruin;
Gould, Todd D.

Publication type:

journal article

Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice.

Published in:

2019

By:

Shen, Linghong;
Sun, Zhe;
Nie, Peng;
Yuan, Ruosen;
Cai, Zhaohua;
Wu, Caizhe;
Hu, Liuhua;
Jin, Shuxuan;
Zhou, Hu;
Zhang, Xiaokun;
He, Ben

Publication type:

journal article

Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway.

Published in:

British Journal of Pharmacology, 2019, v. 176, n. 14, p. 2465, doi. 10.1111/bph.14674

By:

Zhao, Wei‐Bo;
Lu, Qun;
Nguyen, My‐Nhan;
Su, Yidan;
Ziemann, Mark;
Wang, Li‐Na;
Kiriazis, Helen;
Puthalakath, Hamsa;
Sadoshima, Junichi;
Hu, Hou‐Yuan;
Du, Xiao‐Jun

Publication type:

Article

β3‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma.

Published in:

British Journal of Pharmacology, 2019, v. 176, n. 14, p. 2509, doi. 10.1111/bph.14660

By:

Calvani, Maura;
Bruno, Gennaro;
Dal Monte, Massimo;
Nassini, Romina;
Fontani, Filippo;
Casini, Arianna;
Cavallini, Lorenzo;
Becatti, Matteo;
Bianchini, Francesca;
De Logu, Francesco;
Forni, Giulia;
Marca, Giancarlo;
Calorini, Lido;
Bagnoli, Paola;
Chiarugi, Paola;
Pupi, Alberto;
Azzari, Chiara;
Geppetti, Pierangelo;
Favre, Claudio;
Filippi, Luca

Publication type:

Article

β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Published in:

2019

By:

Igawa, Yasuhiko;
Aizawa, Naoki;
Michel, Martin C.

Publication type:

journal article

Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Published in:

2019

By:

Civciristov, Srgjan;
Halls, Michelle L.

Publication type:

journal article

Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Published in:

2019

By:

Arioglu‐Inan, Ebru;
Kayki‐Mutlu, Gizem;
Michel, Martin C.;
Arioglu-Inan, Ebru;
Kayki-Mutlu, Gizem

Publication type:

journal article

Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Published in:

2019

By:

Okeke, Katerina;
Angers, Stephane;
Bouvier, Michel;
Michel, Martin C.

Publication type:

journal article

Adrenoceptors in white, brown, and brite adipocytes.

Published in:

2019

By:

Evans, Bronwyn A.;
Merlin, Jon;
Bengtsson, Tore;
Hutchinson, Dana S.

Publication type:

journal article

β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Published in:

2019

By:

Du, Xiao‐Jun;
Zhao, Wei‐Bo;
Nguyen, My‐Nhan;
Lu, Qun;
Kiriazis, Helen;
Du, Xiao-Jun;
Zhao, Wei-Bo;
Nguyen, My-Nhan

Publication type:

journal article

Updates in the function and regulation of α1 -adrenoceptors.

Published in:

2019

By:

Akinaga, Juliana;
García‐Sáinz, J. Adolfo;
S. Pupo, André;
García-Sáinz, J Adolfo

Publication type:

journal article

Issue Information.

Published in:: British Journal of Pharmacology, 2019, v. 176, n. 14, p. 2337, doi. 10.1111/bph.14411
Publication type:: Article

Function of cAMP scaffolds in obstructive lung disease: Focus on epithelial-to-mesenchymal transition and oxidative stress.

Published in:

2019

By:

Zuo, Haoxiao;
Cattani‐Cavalieri, Isabella;
Valença, Samuel Santos;
Musheshe, Nshunge;
Schmidt, Martina;
Cattani-Cavalieri, Isabella

Publication type:

journal article

What makes the α1A -adrenoceptor gene product assume an α1L -adrenoceptor phenotype?

Published in:

2019

By:

White, Carl W.;
Junior, Edilson Dantas;
Lim, Linzi;
Ventura, Sabatino;
da Silva Junior, Edilson Dantas

Publication type:

journal article

Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Published in:

2019

By:

Bahari, Zahra;
Meftahi, Gholam Hossein

Publication type:

journal article

β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors.

Published in:

2019

By:

Dal Monte, Massimo;
Calvani, Maura;
Cammalleri, Maurizio;
Favre, Claudio;
Filippi, Luca;
Bagnoli, Paola

Publication type:

journal article

Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Published in:

2019

By:

Chia, Ling Yeong;
Evans, Bronwyn A.;
Mukaida, Saori;
Bengtsson, Tore;
Hutchinson, Dana S.;
Sato, Masaaki

Publication type:

journal article

Works matching IS 00071188 AND DT 2019 AND VI 176 AND IP 14

Adrenoceptors-New roles for old players.

Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.

Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.

Bradykinin increases BP in endotoxemic rat: functional and biochemical evidence of angiotensin II AT<sub>1</sub> /bradykinin B<sub>2</sub> receptor heterodimerization.

Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB<sub>1</sub> receptors.

(R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.

Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE<sup>-/-</sup> mice.

Stimulation of β‐adrenoceptors up‐regulates cardiac expression of galectin‐3 and BIM through the Hippo signalling pathway.

β<sub>3</sub>‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma.

β<sub>3</sub> -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Cardiac β<sub>3</sub> -adrenoceptors-A role in human pathophysiology?

Agonist-induced desensitisation of β<sub>3</sub> -adrenoceptors: Where, when, and how?

Adrenoceptors in white, brown, and brite adipocytes.

β-Adrenoceptor activation affects galectin-3 as a biomarker and therapeutic target in heart disease.

Updates in the function and regulation of α<sub>1</sub> -adrenoceptors.

Issue Information.

Function of cAMP scaffolds in obstructive lung disease: Focus on epithelial-to-mesenchymal transition and oxidative stress.

What makes the α<sub>1A</sub> -adrenoceptor gene product assume an α<sub>1L</sub> -adrenoceptor phenotype?

Spinal α<sub>2</sub> -adrenoceptors and neuropathic pain modulation; therapeutic target.

β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β<sub>3</sub> -adrenoceptors.

Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.